1. Home
  2. GRFS vs VRNS Comparison

GRFS vs VRNS Comparison

Compare GRFS & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • VRNS
  • Stock Information
  • Founded
  • GRFS 1940
  • VRNS 2004
  • Country
  • GRFS Spain
  • VRNS United States
  • Employees
  • GRFS N/A
  • VRNS N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • VRNS Computer Software: Prepackaged Software
  • Sector
  • GRFS Health Care
  • VRNS Technology
  • Exchange
  • GRFS Nasdaq
  • VRNS Nasdaq
  • Market Cap
  • GRFS 5.5B
  • VRNS 5.0B
  • IPO Year
  • GRFS 2006
  • VRNS 2014
  • Fundamental
  • Price
  • GRFS $7.27
  • VRNS $44.19
  • Analyst Decision
  • GRFS Strong Sell
  • VRNS Buy
  • Analyst Count
  • GRFS 1
  • VRNS 19
  • Target Price
  • GRFS N/A
  • VRNS $59.44
  • AVG Volume (30 Days)
  • GRFS 704.7K
  • VRNS 1.4M
  • Earning Date
  • GRFS 01-01-0001
  • VRNS 02-04-2025
  • Dividend Yield
  • GRFS N/A
  • VRNS N/A
  • EPS Growth
  • GRFS N/A
  • VRNS N/A
  • EPS
  • GRFS 0.27
  • VRNS N/A
  • Revenue
  • GRFS $7,814,096,584.00
  • VRNS $546,535,000.00
  • Revenue This Year
  • GRFS $9.31
  • VRNS $14.01
  • Revenue Next Year
  • GRFS $7.44
  • VRNS $11.83
  • P/E Ratio
  • GRFS $31.76
  • VRNS N/A
  • Revenue Growth
  • GRFS 7.21
  • VRNS 12.07
  • 52 Week Low
  • GRFS $5.30
  • VRNS $41.13
  • 52 Week High
  • GRFS $9.96
  • VRNS $60.58
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 43.85
  • VRNS 37.58
  • Support Level
  • GRFS $7.00
  • VRNS $43.88
  • Resistance Level
  • GRFS $7.53
  • VRNS $46.34
  • Average True Range (ATR)
  • GRFS 0.24
  • VRNS 1.26
  • MACD
  • GRFS -0.01
  • VRNS 0.27
  • Stochastic Oscillator
  • GRFS 27.00
  • VRNS 23.35

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About VRNS Varonis Systems Inc.

Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.

Share on Social Networks: